// App-Quantinova.ai

: Anti-Factor Xa levels correlate with recurrent venous thromboembolism and clinically relevant bleeding in patients receiving low-molecular-weight heparin

Researchers

Presenter

  • Luis Jara-Palomares

Principal Investigators

  • Samira Marin-Romero

  • Maria Isabel Asensio-Cruz

  • Teresa Elias-Hernandez

  • Rocio Ortega-Rivera

  • Remedios Otero-Candelera

  • Emilio Montero-Romero

  • Rodrigo Tallon-Aguilar

  • Maria Dolores Ucero-Leon

  • Manuel Arellano-Ceballos

  • Maria Rosario Ruiz-Serrano De La Espada

  • Candido Fernandez-Garcia

  • Jose Mara Sanchez-Diaz

  • Veronica Sanchez-Lopez

  • Elena Arellano-Orden

  • Marta Ferrer-Galvan

  • Stefano Barco

Medical Centers

  • Surgical Medical Unit of Respiratory Diseases. Hospital Universitario Virgen del Rocío. CIBERES, Instituto de Salud Carlos III, Madrid., Sevilla, Spain

  • Hematology Service, Hospital Universitario Virgen del Rocio, Sevilla, Spain

  • Surgical Medical Unit of Respiratory Diseases. Hospital Universitario Virgen del Rocío., Sevilla, Spain

  • Hospital Universitario Virgen del Rocio, Sevilla, Spain

  • Instituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Seville, Spain

  • Pulmonologist. Hospital Virgen Macarena, Sevilla, Sevilla, Spain

  • Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg University, Mainz, Germany, Mainz, Rheinland-Pfalz, Germany

Locations

  • Spain

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Heparin

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A